Robert Nelsen, Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 486,164 shares at $48.36 ($24.0M) on 2017-02-27, disclosed to the SEC on 2017-03-01.
Open-market sale of $24.0M AGIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.36 | 53,985 | $2.6M | 10.9% |
| 2 | $48.36 | 53,985 | $2.6M | 10.9% |
| 3 | $49.13 | 83,750 | $4.1M | 17.1% |
| 4 | $49.13 | 83,750 | $4.1M | 17.1% |
| 5 | $50.28 | 57,488 | $2.9M | 12.0% |
| 6 | $50.28 | 57,488 |
| $2.9M |
| 12.0% |
| 7 | $49.47 | 27,622 | $1.4M | 5.7% |
| 8 | $49.47 | 27,622 | $1.4M | 5.7% |
| 9 | $50.18 | 20,237 | $1.0M | 4.2% |
| 10 | $50.18 | 20,237 | $1.0M | 4.2% |
| Total | $49.36 avg | 486,164 | $24.0M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |